Drugs / [F-18] flurothymidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04271436 | Apr 2021 → Jan 2025 | cancer | Washington University School of Medicine | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18] flurothymidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04271436 ↗ |